GHRS - CIK 0001855129
GH Research PLC trades as GHRS and has a market capitalization of $1.29 B, making it the #2450 largest US-listed company by market value. This page tracks GH Research PLC through 186 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| 6-K | - | 2026-05-21 |
| EFFECT | - | 2026-05-19 |
| SCHEDULE 13G/A | - | 2026-05-18 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| 6-K | - | 2026-05-14 |
| F-3 | - | 2026-05-14 |
| Prospectus supplement | 424B5 | 2026-05-14 |
| 6-K | - | 2026-05-14 |
The largest companies sharing GH Research PLC's SEC industry classification (pharmaceutical preparations).
GH Research PLC (GHRS) has a market capitalization of $1.29 B as of 2026-06-10, ranking #2450 among US-listed companies.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.